期刊文献+

滋阴补阳方序贯联合拮抗剂方案对卵巢低反应体外受精结局的影响 被引量:9

Effects of Ziyin Buyang Sequential Formula combined antagonist on the outcome of poor ovarian response in vitro fertilization
原文传递
导出
摘要 目的:观察滋阴补阳方序贯联合拮抗剂对卵巢低反应(POR)患者体外受精-胚胎移植(IVF-ET)临床疗效的影响,探讨中药对POR卵巢反应性、卵母细胞质量、妊娠率的影响及其在辅助生殖中应用的思路。方法:将进入IVF-ET周期符合POR患者64例分为治疗组(滋阴补阳方序贯+拮抗剂)32例及对照组(拮抗剂)32例。比较两组在促性腺激素(Gn)天数、总量、注射人绒毛膜促性腺激素(HCG)日雌二醇(E2)、取卵数、获卵数、MⅡ卵数、MⅡ卵受精率、可移植胚胎数、优质胚胎数、优质胚胎率、移植率、生化妊娠率和临床妊娠率。结果:治疗后治疗组获卵数、MⅡ卵数、可移植胚胎数、优质胚胎数优于对照组(P<0.05,P<0.01),治疗组Gn总量、Gn天数、HCG日E2、取卵数、MⅡ卵受精率、移植率、生化妊娠率、临床妊娠率优于对照组,但差异无统计学意义。结论:滋阴补阳方序贯能增加POR患者拮抗剂周期的获卵数,提高卵子质量,增加优质胚胎数,从而提高妊娠率。 Objective:To observe the effect of the Ziyin Buyang Sequential Formula combined with antagonist on the clinical efficacy of poor ovarian response(POR)in the period of in vitro fertilization and embryo transfer(IVF-ET)and to investigate the effect of Ziyin Buyang Sequential Formula on ovarian responsiveness,oocyte quality and pregnancy rate in POR patients and the thoughts on the application of traditional Chinese medicine in auxiliary reproductive technology.Methods:A total of 64 patients with POR infertility who need to enter the IVF-ET cycle were randomly divided into the treatment group(Ziyin Buyang Sequential Formula with antagonist),control group(antagonist),32 cases in each group.Between the two groups in gonadotropin(Gn)days,Gn dosage,estradiol(E2)level on the day of injection of human chorionic gonadotropin(HCG),and the number of retrieved oocytes,oocytes,MⅡoocytes,MⅡoocytes fertilization rate,number of embryos,the number of high quality embryos,high quality embryo rate,transplantation rate,biochemical pregnancy rate and clinical pregnancy rate.Results:After treatment,the number of oocytes,the number of MⅡoocytes,the number of transplantable embryos and the number of high quality embryos were better than those of the control group,the difference was statistically significant(P<0.05,P<0.01).The Gn dosage,Gn days,E2 level on the HCG day,oocyte count,MⅡfertilization rate,transplant rate,biochemical pregnancy rate and clinical pregnancy rate in the treatment group were better than those in the control group,but the difference was not statistically significant.Conclusion:Ziyin Buyang Sequential Formula could increase the number of oocyte in the cycle of POR antagonist,improve the quality of oocyte,increase the number of high quality embryos,and increase the pregnancy rate.
作者 王飞虹 谈勇 殷燕云 周竞 周阁 WANG Fei-hong;TAN Yong;YIN Yan-yun;ZHOU Jing;ZHOU Ge(Department of Productive Medicine,Jiangsu Provincial Hospital of Chinese Medicine,Nanjing 210029,China)
出处 《中华中医药杂志》 CAS CSCD 北大核心 2019年第7期3327-3329,共3页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 江苏省自然科学基金青年基金项目(No.BK20151043)~~
关键词 滋阴补阳方序贯 卵巢低反应 拮抗剂方案 体外受精-胚胎移植 Ziyin Buyang Sequential Formula Poor ovarian response Antagonist scheme In vitro fertilization and embryo transfer
  • 相关文献

参考文献4

二级参考文献56

  • 1马瑞芬,陆海娟,施孝文.中药合穴位针刺治疗排卵障碍性不孕疗效观察[J].浙江中西医结合杂志,2006,16(1):62-62. 被引量:19
  • 2Polyzos NP, Devroey P. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril, 2011, 96(5): 1058-61.e7.
  • 3Gareia JE, Jones GS, Acosta AA, et al. Human menopausal gonadotropin/human chorionic gonadotropin follicular matu- ration for oocyte aspiration: phase II, 1981. Fertil Steril, 1983, 39(2):167-73.
  • 4Campbell S, Goessens L, Goswamy R, et al. Real-time ullrasonog- mphy for determination of ovarian morphology and volume. A possible early screening test for ovarian cancer?. Lancet, 1982, 20 (1):425-6.
  • 5Gougeon A. Ovarian follicular growth in humans: ovarian ageing and population of growing follicles. Maturitas, 1998, 30(2): 137-42.
  • 6Chang MY, Chiang CH, Hsieh TF, etal. Use ofthe antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril, 1998, 69(3):505-10.
  • 7Fetranretti AP, La Marea A, Fauster BC, et al. ESHRE working group on poor ovarian respone definition. ESHRE consensus on the definition of'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod, 2011, 26(7): 1616-24.
  • 8EI-Toukhy T, Khalaf Y, Hart R, et al. Yotmg age does not protect against the adverse effects of reduced ovarian reserve an eight year study. Hum Reprod, 2002, 17(6): 1519-24.
  • 9Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting meagures of ovarian reserve: a committee opinion. Fertil Steril, 2012, 98(6): 1407-15.
  • 10Tsepelidis S, Devreker F, Demeestere I, et al. Stable serum levels of anti-Miillerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. Hum Reprod, 2007, 22(7): 1837-40.

共引文献251

同被引文献104

引证文献9

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部